In Europe, we had mixed results, many countries growing and others, quiet. At this time, it's difficult to draw any conclusions regarding the impact of financial and banking worries on the European market. It appears the market has continued to invest in better clinical capability, albeit, in a sporadic and somewhat lumpy fashion.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts